On this episode, we are joined by two MUSC 4th year pharmacy students, Ian and Allison. We discuss the CREDENCE trial (NEJM 2019) that showed the benefit of canagliflozin for renal protection in patients with diabetes. We also review the pathophysiology, diagnosis, and treatment of urinary tract infections.  If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.